**4.4 Reflections and future recommendations**

Only preliminary screening of phytochemicals was done on crude extracts. Isolation of active pure compounds was only done on roots (3 compound identified) and not on leaves, even though leaves showed so much active compounds. This compound identification still needs to be done and testing of them has not been done either. Both leaves and roots extracts showed the presence of saponins. However, the identification and isolation of those specific saponins has not been done. Intensive work still needs to be performed regarding the mutagenicity or genotoxicity of the plant extracts for the confirmation of the safety of *Asparagus laricinus Burch.*, as the root cytotoxicity results were promising, while the safety of the leaves also needs to be investigated. The toxicological study of the roots of *Asparagus laricinus Burch.* confirmed that the plant extract did not cause any harm *in vivo* and can thus be considered as non-toxic. However, the *in vivo* anticancer activity of the root extract has not been done in order to confirm or corroborate the results obtained in the screening study that was conducted. Both *in vitro* and *in vivo* anticancer, cytotoxicity and mutagenicity studies still need to be done on the leaf extract. The ability of the crude extract of this plant as an antibacterial agent was confirmed, and findings supported the use of this plant against infections. However, not all ethnobotanical claims of this plant have been confirmed as the anti-TB activity, anti-inflammatory activity and its ability as a diuretic still needs to be elucidated.
